)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Summit Therapeutics
Summit Therapeutics (SMMT) investor relations material
Summit Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary10 Jun, 2026
Opening remarks and agenda
Meeting called to order with introductions of executive team, board members, and external counsel.
Notice of meeting and proxy materials were mailed to all stockholders on or about April 17, 2026.
Four matters were set for voting: election of directors, ratification of auditors, executive compensation, and amendment to the stock incentive plan.
Board and executive committee updates
Board nominees for terms expiring in 2027 were presented, including current executives and independent directors.
Shareholder proposals
Ratification of PricewaterhouseCoopers LLP as independent auditors for 2026.
Advisory vote on executive compensation.
Amendment to the 2020 Stock Incentive Plan to increase shares by eight million.
Strategic purpose of the stock plan expansion
Clinical expertise among 2027 board nominees
Shareholder sentiment on executive compensation
8 million share increase to stock incentive plan
Board nominees for the 2027 term
Deadline for disclosing final voting results
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Summit Therapeutics
- Ivonescimab leads PD-1/VEGF innovation with strong survival data and broad late-stage pipeline.SMMT
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Ivonescimab plus chemo cut death risk by 34% vs. tislelizumab in 1L squamous NSCLC.SMMTStatus update1 Jun 2026
- Q1 2026 net loss reached $189.4M; liquidity concerns persist as key trial data approach.SMMTQ1 20261 May 2026
- Annual meeting seeks approval for directors, auditor, executive pay, and stock plan amendment.SMMTProxy filing17 Apr 2026
- Annual meeting to vote on directors, auditor, executive pay, and stock plan amendment.SMMTProxy filing17 Apr 2026
- Ivonescimab advances with FDA BLA, strong cash, and major Phase III milestones ahead.SMMTQ4 202510 Apr 2026
- Board recommends approval of all proposals, including director elections and stock plan amendment.SMMTProxy filing6 Apr 2026
- Ivonescimab demonstrates best-in-class efficacy and broad expansion potential in global oncology.SMMTThe Citizens Life Sciences Conference 202611 Mar 2026
- Ivonescimab advances globally with strong phase III data and key regulatory milestones ahead.SMMTTD Cowen 46th Annual Health Care Conference2 Mar 2026
Next Summit Therapeutics earnings date
Q2 20264 Aug, 2026
Summit Therapeutics
Next Summit Therapeutics earnings date
Q2 20264 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage